Antibacterial agent 169, identified by its CAS number 2879255-03-3, is a synthetic compound designed to exhibit antimicrobial properties, particularly against a range of bacterial pathogens. While specific characteristics such as its molecular structure, mechanism of action, and spectrum of activity may vary, compounds in this category typically function by inhibiting bacterial cell wall synthesis, protein synthesis, or nucleic acid replication. This agent may be evaluated for its efficacy in treating infections, its pharmacokinetic properties, and its safety profile in clinical settings. Additionally, it is essential to consider its potential for resistance development, which is a significant concern in antibacterial therapy. The compound's solubility, stability, and formulation characteristics are also critical for its application in pharmaceutical products. As with any antibacterial agent, ongoing research and clinical trials are necessary to fully understand its therapeutic potential and to establish guidelines for its use in medical practice.

Antibacterial agent 169

2879255-03-3: Antibacterial agent 169, identified by its CAS number 2879255-03-3, is a synthetic compound designed to exhibit antimicrobial properties, particularly against a range of bacterial pathogens. While specific characteristics such as its molecular structure, mechanism of action, and spectrum of activity may vary, compounds in this category typically function by inhibiting bacterial cell wall synthesis, protein synthesis, or nucleic acid replication. This agent may be evaluated for its efficacy in treating infections, its pharmacokinetic properties, and its safety profile in clinical settings. Additionally, it is essential to consider its potential for resistance development, which is a significant concern in antibacterial therapy. The compound's solubility, stability, and formulation characteristics are also critical for its application in pharmaceutical products. As with any antibacterial agent, ongoing research and clinical trials are necessary to fully understand its therapeutic potential and to establish guidelines for its use in medical practice.

<p>Antibacterial agent 169 (Compound 28), a pyrrolamide-type GyrB/ParE inhibitor, exhibits antibacterial properties by inhibiting Gyrase and Topo IV in Staphylococcus aureus. It has IC 50 values of 49 nmol/L and 1.513 μmol/L, respectively [1].</p>

CAS 2879255-03-3

Antibacterial agent 169

Antibacterial agent 169

Ref: TM-T85659